The Market Herald: AusCann (ASX:AC8) signs five-year lease deal for R&D facility

AusCann CEO Layton Mills commented on the deal.


"This will further reduce our non-R&D-related cash outflow, allowing the company to focus resources on expanding our research pipeline and commercialising our lead products in development," he said.


"SCI is in an exponential growth phase of its business and the R&D facility developed by AusCann presents the business with a great opportunity to accelerate this growth," SCI Managing Director Cameron Scadding added.


Read the full article here or below.